DICE — Dice Therapeutics Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMid Cap
Dice Therapeutics Inc expected to post a loss of 69 cents a share - Earnings Preview
Brief: Eli Lilly Announces Extension Of Tender Offer To Acquire Dice
MoonLake Immunotherapeutics explores sale-sources
MoonLake Immunotherapeutics explores sale-sources
U.S. stocks weekly: Wings clipped
U.S. RESEARCH ROUNDUP-Dice Therapeutics, Mongodb, Valvoline
U.S. stocks weekly: Wings clipped
U.S. RESEARCH ROUNDUP-Amazon.com, Fedex, Nike
Refinitiv Newscasts - US Day Ahead: Market nerves set in ahead of Powell testimony
U.S. STOCKS ON THE MOVE-US Foods, BridgeBio, CureVac
U.S. STOCKS ON THE MOVE-Vera Therapeutics, FedEx, US Foods
Dice Therapeutics hits record high on $2.4 bln buyout deal by Eli Lilly
U.S. STOCKS ON THE MOVE-Innovative Eyewear, BranchOut Food, Estee Lauder
U.S. STOCKS ON THE MOVE-Cano Health, Arcellx, Dice Therapeutics
Brief: Dice Therapeutics Says Likely Required To Pay Eli Lilly Deal Termination Fee Of $92.0 Mln - SEC Filing
Dice Therapeutics jumps on $2.4 billion buyout deal by Eli Lilly
Eli Lilly to buy Dice Therapeutics in $2.4 billion deal (updated)
Brief: Lilly To Acquire Dice Therapeutics To Advance Innovation In Immunology
Eli Lilly to buy Dice Therapeutics in $2.4 billion deal